Abstract
The aim of this study was to investigate the anti-inflammatory effects and mechanism of isovitexin on ulcerative colitis mice and RAW264.7 cells. The results showed that isovitexin had strong antioxidant and anti-inflammatory effects, and could restore intestinal barrier integrity (p < 0.01). In addition, isovitexin inhibited the expression of MyD88, TLR4 and NF-κB p65 proteins. At the same time, isovitexin can inhibit the activation of MAPK/NF-κB signaling pathway in RAW264.7 cells. In conclusion, isovitexin has a protective effect on UC mice, and its improvement mechanism of UC might be related to MAPK/NF-κB signaling pathway.
Graphical Abstract
![](/cms/asset/14e51f7b-d9d3-47c1-8c1f-9e0b1b8c7e0f/ganp_a_2142121_uf0001_c.jpg)
Ethical approval
This research was conducted according to approved animal protocols and guidelines established by the Experimental Animals of Yunnan University of Traditional Chinese Medicine (Kunming, China) (Approval Number: SYXK (Dian) K2017-0005). We have done our best to minimize animal suffering and to reduce the number of animals used.
Disclosure statement
No potential conflict of interest was reported by the author(s).
Data availability statement
All datasets generated for this study are included in the article.